Pfizer's Heart Races Of AstraZeneca Amidst Rumored Deal & Drug Approval

By: via Benzinga
Pfizer (NYSE: PFE) continues to pursue AstraZeneca plc (NYSE: AZN) despite three rejections this year and grave concern by U.K. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.